SHH and myocardial infarction: Genetic therapy was tested with SHH in combination with a small molecule inhibitor AMD3100-stimulated progenitor-cell mobilization and showed promising results of reduced cardiac fibrosis and promoted the development of capillaries and smooth-muscle–containing vessels after MI [111].